Transgenic Schizochytrium as a Promising Oral Vaccine Carrier: Potential Application in the Aquaculture Industry
2024

Transgenic Schizochytrium as a Promising Oral Vaccine Carrier for Aquaculture

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ma Ke, Deng Lei, Wu Yuanjie, Gao Yuan, Fan Jianhua, Wu Haizhen, Calado Ricardo

Primary Institution: East China University of Science and Technology

Hypothesis

Can transgenic Schizochytrium limacinum serve as an effective oral vaccine carrier in aquaculture?

Conclusion

The study found that Schizochytrium limacinum SR21 can effectively act as an oral vaccine carrier, enhancing immune responses in zebrafish and koi carp.

Supporting Evidence

  • Zebrafish fed with recombinant Schizochytrium showed specific immune responses in the intestine.
  • Expression levels of immune-related genes were significantly upregulated post-immunization.
  • Koi carp fed with recombinant Schizochytrium exhibited increased production of specific antibodies.

Takeaway

This study shows that a special type of algae can help fish get better protection against diseases when they eat it.

Methodology

The study involved feeding zebrafish and koi carp with recombinant Schizochytrium expressing the FBA antigen and assessing immune responses.

Limitations

The study did not evaluate long-term immune effects or the safety of using transgenic microalgae in natural environments.

Participant Demographics

Zebrafish (Danio rerio) and koi carp (Cyprinus carpio koi) were used as model organisms.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/md22120555

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication